Mixing Second-Hand Smoke and Cystic Fibrosis

Cigarette smoke contains many harmful chemicals that are illustrious to cause cancer and different diseases in people that smoke. Smokers get the best concentration of chemicals, however, second-hand smoke contains enough toxins to cause unwellness in those that frequently breathe it in.

Cigarette smoke conjointly contains irritants that cause inflammation of the airways, and it damages the cilia that line the airways inflicting mucous secretion to become trapped. Inflammation and mucous secretion build-up are issues that exist already in people with CF. Inhaling second-hand smoke makes these problems worse.

Exposure to second-hand smoke will cause problems for people with CF above and on the beyond the issues that it causes for others.

·        Weight loss or poor weight gain: The primary study regarding CF and second-hand smoke was conducted at a site in 1990. The youngsters with CF who were often exposed to second-hand smoke reception gained far more weight throughout the 2 second-hand smoke-free weeks of camp than the youngsters who weren't often exposed to second-hand smoke regularly.

·         Increased respiratory infections: Ever since the 1990 study, several studies have been done that found people with cystic fibrosis who are exposed to second-hand smoke suffer from a lot of frequent and a lot of severe respiratory organ infections than do those that aren't exposed to smoke.

·         Decreased lung function: A study conducted and created some surprising results. The study found that individuals with cystic fibrosis who are exposed to second-hand smoke reception have lung functions 10% lower than did those with CF who aren't exposed to smoke.

References:
Ollaco, J.M., et al. “Interactions Between second-hand Smoke and Genes That Affect Cystic Fibrosis Lung Disease”. JAMA.2008;299(4):417-424.
Schecter, M.S. “CF Lung Health Anthology Part 1: Second-hand Smoke and CF”. 2008. Cystic Fibrosis Foundation
Schechter, M.S. “Non-genetic influences on cystic fibrosis lung disease: The role of sociodemographic characteristics, environmental exposures, and healthcare interventions”. Seminars in Respiratory and Critical Care Medicine. 2003;24(6):639-652.




Comments

Popular posts from this blog

Biomarkers could lead to better treatments for CF patients